AZB and FoxMandal advise Sequoia Capital to invest $15 million in biopharmaceutical company Celon

November 2, 2010 Sequoia has invested Rs. 70 crore ($15 million) in a Hyderabad based biopharmaceutical company Celon Laboratories Limited (Celon). Sequoia thus acquires 33 percent of the share capital of Celon.

AZB & Partners in Delhi represented Sequioa Capital with a team led by partner Gautam Saha along with Senior Associate Sachin Mehta and Associates Dushyant Bagga and Sumati Dwivedi.

Celon was advised by the Hyderabad office of FoxMandal Little, by partner Purnima Kamble.

Read more at www.barandbench.com.

comments powered by Disqus